• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Simultaneous and Complete Genome Sequencing of Influenza A and B with High Coverage by Illumina MiSeq Platform

tetano

Editor, Senior Moderator
J Virol Methods. 2013 Jul 12. pii: S0166-0934(13)00254-1. doi: 10.1016/j.jviromet.2013.07.001. [Epub ahead of print]
Simultaneous and Complete Genome Sequencing of Influenza A and B with High Coverage by Illumina MiSeq Platform.
Rutvisuttinunt W, Chinnawirotpisan P, Simasathien S, Shrestha SK, Yoon IK, Klungthong C, Fernandez S.
Source

Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand. Electronic address: wiriyar@afrims.org.
Abstract

Active global surveillance and characterization of influenza viruses are essential for better preparation against possible pandemic events. Obtaining comprehensive information about the influenza genome can improve our understanding of the evolution of influenza viruses and emergence of new strains, and improve the accuracy when designing preventive vaccines. This study investigated the use of deep sequencing by the next-generation sequencing (NGS) Illumina MiSeq Platform to obtain complete genome sequence information from influenza virus isolates. The influenza virus isolates were cultured from 6 respiratory acute clinical specimens collected in Thailand and Nepal. DNA libraries obtained from each viral isolate were mixed and all were sequenced simultaneously. Total information of 2.6 Gbases was obtained from a 455?14K/mm2 density with 95.76% (8,571,655/8,950,724 clusters) of the clusters passing quality control (QC) filters. Approximately 93.7% of all sequences from Read1 and 83.5% from Read2 contained high quality sequences that were ≥Q30, a base calling QC score standard. Alignments analysis identified three seasonal Influenza A H3N2 strains, one 2009 pandemic Influenza A H1N1 strain and two Influenza B strains. The nearly entire genomes of all six virus isolates yielded equal or greater than 600-fold sequence coverage depth. MiSeq Platform identified seasonal Influenza A H3N2, 2009 pandemic Influenza A H1N1and Influenza B in the DNA library mixtures efficiently.

Copyright ? 2013 The Authors. Published by Elsevier B.V. All rights reserved.
KEYWORDS:

Deep Sequencing, Influenza, NGS, Next-Generation Sequencing

PMID:
23856301
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23856301
 
Back
Top Bottom